Mechanotargeting of cancer cells

Diseased cells such as metastatic cancer cells have markedly different mechanical properties that can be used to improve targeted drug uptake, according to a team of researchers at Penn State.
Many labs around the world are developing nanoparticle-based drug delivery systems to selectively target tumors. They rely on a key-and-lock system in which protein keys on the surface of the nanoparticle click into the locks of a highly expressed protein on the surface of the cancer cell. The cell membrane then wraps around the nanoparticle and ingests it. If enough of the nanoparticles and their drug cargo is ingested, the cancer cell will die.
The adhesive force of the lock and key is what drives the nanoparticle into the cell, says Sulin Zhang, professor of engineering science and mechanics. “It is almost universal that whenever there is a driving force for a process, there always is a resistive force. Here, the driving force is biochemical – the protein-protein interaction.”
The resistive force is mechanical, the energy cost of the membrane wrapping around the nanoparticle. Until now, bioengineers only considered the driving force and designed nanoparticles to optimize the chemical interactions, a targeting strategy called “chemotargeting.” Zhang believes they should also take into account the mechanics of the cells to design nanoparticles to achieve enhanced targeting, which forms a new targeting strategy called “mechanotargeting.”
Read more at nanowerk.com

Image Credit:  Zhang lab/vecteezy.com

News This Week

NanoApps Medical Near-Term Projects

NanoApps Medical is investigating the possibility that superparamagnetic nanoparticles (SPIONs) and other classes of nanoparticles (e.g., gold coated nanoshells) might have the capacity to target cancerous tumors, metastasizing cancer cells, pathogens, etc. to deactivate/eliminate [...]

‘Please do not switch me off!’ People heed begging robot

If a little humanoid robot begged you to not shut it off, would you show compassion? In an experiment designed to investigate how people treat robots when they act like humans, many participants struggled [...]

How Artificial Intelligence is Changing Radiology, Pathology

Artificial intelligence and machine learning tools have the potential to analyze large datasets and extract meaningful insights to enhance patient outcomes, an ability that is proving helpful in radiology and pathology. Images obtained by [...]

Nanoparticle-Based Combination Therapy to Treat Breast, Prostate Cancer

Researchers at the University of East Anglia have developed a new nanoparticle-based cancer therapy to deliver a combination therapy directly to cancer cells. The new therapy, which has been demonstrated to make prostate cancer [...]

AI: ChronWell CEO On Why Consolidation in Healthcare Is A Good Thing

When Joe Rubinsztain started gMed, he was admittedly young—only a few years removed from medical school— and he just didn’t understand leadership that well. “I needed to be abreast of everything and understand everything [...]

Artificial Intelligence for Medical Imaging Market to Top $2B

Healthcare organizations are likely to see a rapidly growing market around artificial intelligence tools for medical imaging, a new report predicts. The market for artificial intelligence (AI) tools to process and analyze medical imaging [...]

Tuberculosis is a killer, but scientists are fighting back with nanobots

Tuberculosis, a bacterial disease which predominantly affects the lungs, isn’t all that common a sight in the United States. On average, fewer than 10,000 cases are reported each year in a country with [...]

Integrated sensor could monitor brain aneurysm treatment

Implantation of a stent-like flow diverter can offer one option for less invasive treatment of brain aneurysms – bulges in blood vessels – but the procedure requires frequent monitoring while the vessels heal. Now, [...]

2018-06-05T08:03:29+00:00

Leave A Comment